Edgestream Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.78M | Buy |
100,730
+2,769
| +3% | +$76.4K | 0.08% | 454 |
|
|
2025
Q1 | $2.78M | Buy |
97,961
+71,544
| +271% | +$2.03M | 0.09% | 402 |
|
|
2024
Q4 | $1.1M | Sell |
26,417
-19,869
| -43% | -$826K | 0.05% | 545 |
|
|
2024
Q3 | $3.09M | Buy |
46,286
+32,202
| +229% | +$2.15M | 0.14% | 261 |
|
|
2024
Q2 | $1.67M | Buy |
+14,084
| New | +$1.67M | 0.08% | 389 |
|
|
2024
Q1 | – | Sell |
-11,088
| Closed | -$1.1M | – | 946 |
|
|
2023
Q4 | $1.1M | Buy |
+11,088
| New | +$1.1M | 0.08% | 415 |
|
|
2022
Q4 | – | Sell |
-2,040
| Closed | -$241K | – | 589 |
|
|
2022
Q3 | $241K | Buy |
+2,040
| New | +$241K | 0.02% | 416 |
|